Taurine/chenodeoxycholic acid ratio as a circulating biomarker of insidious vitamin B deficiency in humans

Madhu Baghel,Sting L. Shi,Himani Patel,Vidya Velagapudi,Abdullah Mahmood Ali,Vijay K. Yadav
DOI: https://doi.org/10.1101/2024.02.15.580499
2024-02-19
Abstract:Deficiency of vitamin B (B ), an essential water-soluble vitamin, leads to irreversible neurological damage, osteoporosis, cardiovascular diseases, and anemia. Clinical tests to detect B deficiency lack specificity and sensitivity. B deficiency is thus insidious because progressive decline in organ functions may go unnoticed until the damage is advanced or irreversible. Here, using targeted unbiased metabolomic profiling in the sera of B -deficient versus control individuals, we set out to identify biomarker(s) of B deficiency. Metabolomic profiling identified 77 metabolites, and Partial least squares discriminant-analysis (PLS-DA) and hierarchical clustering analysis (HCA) showed a differential abundance in B -deficient sera of taurine, xanthine, hypoxanthine, chenodeoxycholic acid, neopterin, and glycocholic acid. Random forest (RF) multivariate analysis identified a taurine/chenodeoxycholic acid ratio, with an AUC score of 1, to be the best biomarker to predict B deficiency. Mechanistically, B deficiency reshaped the transcriptomic and metabolomic landscape of the cell identifying a downregulation of methionine, taurine, urea cycle, and nucleotide metabolism, and an upregulation of Krebs cycle. Thus, we propose taurine/chenodeoxycholic acid ratio in serum as a potential biomarker of B deficiency in humans and elucidate cellular metabolic pathways regulated by B deficiency.
Pharmacology and Toxicology
What problem does this paper attempt to address?